Kurt Gustafson Sells 9,301 Shares of OmniAb (NASDAQ:OABI) Stock

OmniAb, Inc. (NASDAQ:OABI) CFO Kurt Gustafson sold 9,301 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $1.71, for a total value of $15,904.71. Following the sale, the chief financial officer owned 268,851 shares in the company, valued at approximately $459,735.21. This trade represents a 3.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

OmniAb Stock Performance

Shares of OmniAb stock remained flat at $1.71 on Wednesday. The stock had a trading volume of 342,206 shares, compared to its average volume of 375,697. The firm has a market capitalization of $246.17 million, a price-to-earnings ratio of -2.95 and a beta of 0.13. The firm’s 50-day simple moving average is $1.89 and its 200-day simple moving average is $1.76. OmniAb, Inc. has a 12-month low of $1.22 and a 12-month high of $4.02.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of OmniAb in a report on Monday, December 22nd. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $6.67.

Key Stories Impacting OmniAb

Here are the key news stories impacting OmniAb this week:

• Positive Sentiment: Institutional buying and concentrated ownership: several funds (Osaic, AQR, BNP Paribas, Cerity Partners, SG Americas) have recently increased or established stakes; institutional ownership is reported above 70%, which can support liquidity and longer-term stability. MarketBeat OABI page
• Neutral Sentiment: Analyst coverage is mixed: MarketBeat shows an average “Moderate Buy” rating and a mean price target near $6.67, but Weiss Ratings has a “sell (e+)” on the stock — a signal of divergent views that can keep trading range-bound. MarketBeat OABI page
• Neutral Sentiment: Key trading metrics: shares are being reported around $1.71 with a 50-day moving average (~$1.89) and 200-day (~$1.76); negative trailing P/E reflects current losses. These metrics frame risk/reward but do not convey near-term directional catalysts. MarketBeat OABI page
• Negative Sentiment: CEO Matthew W. Foehr sold shares on Feb. 17–18 (totaling 51,597 shares across two filings), reducing his stake modestly; filings: Feb. 18 sale. CEO Feb 18 Form 4 and Feb. 17 sale. CEO Feb 17 Form 4
• Negative Sentiment: CFO Kurt A. Gustafson sold shares on Feb. 17–18 (totaling 16,129 shares across two filings), trimming his holding by a few percent; filings: Feb. 18. CFO Feb 18 Form 4 and Feb. 17. CFO Feb 17 Form 4
• Negative Sentiment: Director Charles S. Berkman sold shares on Feb. 17–18 (totaling 16,663 shares across two filings), reducing his stake by a few percent; filings: Feb. 18. Director Feb 18 Form 4 and Feb. 17. Director Feb 17 Form 4

Hedge Funds Weigh In On OmniAb

Several hedge funds have recently bought and sold shares of OABI. Cadian Capital Management LP increased its stake in OmniAb by 20.7% in the fourth quarter. Cadian Capital Management LP now owns 4,434,954 shares of the company’s stock worth $8,205,000 after purchasing an additional 759,386 shares during the period. Woodline Partners LP bought a new position in shares of OmniAb in the third quarter worth about $4,571,000. Geode Capital Management LLC grew its holdings in shares of OmniAb by 17.0% in the fourth quarter. Geode Capital Management LLC now owns 2,722,692 shares of the company’s stock worth $5,038,000 after purchasing an additional 396,456 shares during the last quarter. Private Management Group Inc. increased its stake in OmniAb by 1.1% in the 2nd quarter. Private Management Group Inc. now owns 2,558,045 shares of the company’s stock worth $4,451,000 after buying an additional 28,286 shares during the period. Finally, Kent Lake PR LLC lifted its holdings in OmniAb by 677.8% during the 2nd quarter. Kent Lake PR LLC now owns 1,750,000 shares of the company’s stock valued at $3,045,000 after buying an additional 1,525,000 shares in the last quarter. Institutional investors own 72.08% of the company’s stock.

OmniAb Company Profile

OmniAb, Inc (NASDAQ: OABI) operates as a biotechnology company specializing in the discovery and development of therapeutic antibodies. The company’s integrated antibody discovery platform combines proprietary transgenic animal models, in vitro screening, and in silico engineering to accelerate lead identification and optimization. OmniAb offers both fee-for-service collaborations and license agreements, enabling biopharmaceutical partners to leverage its suite of technologies for programs spanning oncology, immunology, and other therapeutic areas.

Founded in 2016 and headquartered in Seattle, Washington, OmniAb went public in May 2021.